Incidence of Invasive and Noninvasive Pneumococcal Pneumonia Hospitalizations in People Aged ≥50 Years: Assessing Variability Across Denmark and Spain

Author:

López-Lacort Mónica12,Amini Marzyeh3,Emborg Hanne-Dorthe4ORCID,Nielsen Jens4ORCID,McDonald Scott A5,Valentiner-Branth Palle4,Díez-Domingo Javier126,Orrico-Sánchez Alejandro126ORCID

Affiliation:

1. Vaccine Research Department of Fisabio-Public Health , Valencia, Spain

2. CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III , Madrid , Spain

3. P95 Epidemiology and Pharmacovigilance , Leuven , Belgium

4. Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut , Copenhagen , Denmark

5. Centre for Infectious Disease Control, National Institute for Public Health and the Environment , Amsterdam , The Netherlands

6. Chair of Vaccines, Universidad Católica de Valencia San Vicente Mártir , Valencia , Spain

Abstract

Abstract Determining pneumococcal pneumonia (PP) burden in the elderly population is challenging due to limited data on invasive PP (IPP) and, in particular, noninvasive PP (NIPP) incidence. Using retrospective cohorts of adults aged ≥50 years in Denmark (2 782 303) and the Valencia region, Spain (2 283 344), we found higher IPP hospitalization rates in Denmark than Valencia (18.3 vs 9/100 000 person-years [PY], respectively). Conversely, NIPP hospitalization rates were higher in Valencia (48.2 vs 7.2/100 000 PY). IPP and NIPP rates increased with age and comorbidities in both regions, with variations by sex and case characteristics (eg, complications, mortality). The burden of PP in adults is substantial, yet its true magnitude remains elusive. Discrepancies in clinical practices impede international comparisons; for instance, Valencia employed a higher frequency of urinary antigen tests compared to Denmark. Additionally, coding practices and prehospital antibiotic utilization may further influence these variations. These findings could guide policymakers and enhance the understanding of international disparities in disease burden assessments.

Funder

Innovative Medicines Initiatives 2 Joint Undertaking

Dutch Ministry of Health, Welfare and Sport

European Union’s Horizon 2020 research innovation program

Publisher

Oxford University Press (OUP)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3